Doseology Sciences Inc. DOSEF
0.10 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.1337 Day range 0.1337
0.0071 52-week range 1.00
- YTD
- -72.49%
- 1 year
- -90.37%
Financial health
Altman Z-Score
-6.33 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -10.3×
FY 2020 5y median -10.6× FY 2025
P/S 108×
FY 2020 5y median 108× FY 2025
P/B 2.4×
FY 2020 5y median 9.9× FY 2025
P/FCF -9.9×
FY 2020 5y median -14.0× FY 2025
EV/EBITDA -7.1×
FY 2020 5y median -9.8× FY 2025
EV/Sales 74.6×
FY 2020 5y median 74.6× FY 2025
FCF Yield -10.1%
FY 2020 5y median -7.1% FY 2025
Profitability
Gross Margin 60.4%
FY 2020 5y median 60.4% FY 2025
Operating Margin -1108.2%
FY 2020 5y median -1108.2% FY 2025
Net Margin -1052.2%
FY 2020 5y median -1052.2% FY 2025
ROE -23.5%
FY 2020 5y median -63.1% FY 2025
ROIC -24.3%
FY 2020 5y median -48.3% FY 2025
ROA -30.0%
FY 2020 5y median -30.8% FY 2025
Growth (YoY)
Revenue -68.3%
FY 2020 FY 2025
Operating Income 8.3%
FY 2020 FY 2025
EPS (diluted) 10.7%
FY 2020 FY 2025
Free Cash Flow -45.6%
FY 2020 FY 2025
Financial Health
Current Ratio 21.6×
FY 2020 5y median 13.6× FY 2025
Quick Ratio 21.3×
FY 2020 5y median 13.5× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 3.2×
FY 2020 5y median 2.2× FY 2025
Interest Coverage 0.0×
FY 2020 5y median -21.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-06-30